I. Vercruysse et al., INCREASE IN PLASMA PROPRANOLOL CAUSED BY NICARDIPINE IS DEPENDENT ON THE DELIVERY RATE OF PROPRANOLOL, European Journal of Clinical Pharmacology, 49(1-2), 1995, pp. 121-125
The influence of a single oral dose of nicardipine 30 mg on the pharma
cokinetics and pharmacodynamics of propranolol 80 mg given as a conven
tional release formulation and as a slow release formulation was studi
ed in two separate groups of 12 healthy volunteers. Nicardipine double
d the area under the curve (AUG) and C-max of propranolol when given a
s a conventional formulation, but increased it only slightly when give
n as a slow release formulation. This pharmacokinetic interaction did
not result in clinically relevant changes in pharmacodynamic responses
. These result's indicate that the enhancement of the bioavailability
of propranolol by coadministration of nicardipine is dependent on the
delivery rate of propranolol, suggesting that the interaction is mainl
y due to shortterm haemodynamic effects of nicardipine leading to satu
ration of hepatic enzymes or functional shunting.